Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

PKAγ Activators

PKAγ activators comprise a diverse array of chemical compounds that facilitate the enhancement of PKAγ's functional activity through the elevation of intracellular cyclic adenosine monophosphate (cAMP) levels or by mimicking its action. Forskolin is a potent activator that directly stimulates adenylyl cyclase, leading to an increase in cAMP, which is essential for PKAγ activation; the cAMP binds to the regulatory subunits of PKAγ, causing the release of active catalytic subunits that are then free to phosphorylate target proteins. Similarly, IBMX and Cilostamide function as non-specific and PDE3-specific inhibitors of phosphodiesterases, respectively, preventing the breakdown of cAMP, resulting in sustained activation of PKAγ. Additionally, Sp-cAMPS and 8-Br-cAMP are cAMP analogs that resist degradation and directly activate PKAγ by engaging with its regulatory subunits, while H-89, though typically a PKA inhibitor, can under certain conditions, allosterically enhance PKAγ activity.

The action of PKAγ is further potentiated by compounds like Rolipram and Dipyridamole that inhibit PDE4 and non-specific phosphodiesterases, respectively, leading to an accumulation of cAMP within the cell and consequent activation of PKAγ. Milrinone and Anagrelide, both targeting phosphodiesterase 3, increase cAMP levels, further driving the activation of PKAγ. Vinpocetine selectively inhibits phosphodiesterase 1, contributing to the rise in cAMP and subsequent PKAγ activation, while Zardaverine, also a phosphodiesterase inhibitor, enhances cAMP concentration, thereby facilitating PKAγ activation. Collectively, these activators work through interconnected pathways that converge on the elevation of cAMP or its analogs, leading to a cascade of intracellular events that activate PKAγ, which then phosphorylates various substrates to exert its physiological effects. The specificity of these chemical activators in targeting the signaling pathways that lead to PKAγ activation underscores the intricate regulatory mechanisms that modulate its activity within the cellular context.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Direct activator of adenylate cyclase, leading to increased cAMP levels, which in turn activate PKAγ by binding to the regulatory subunits causing a conformational change that releases active PKAγ catalytic subunits.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-specific inhibitor of phosphodiesterases, which increases cAMP levels by preventing its degradation, thereby indirectly enhancing the activation of PKAγ through increased availability of cAMP.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Stimulates adenylate cyclase via beta-adrenergic receptors, increasing intracellular cAMP levels and consequently activating PKAγ.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$94.00
$186.00
71
(2)

A potent and selective inhibitor of PKA, which paradoxically can upregulate PKA activity through feedback mechanisms. By inhibiting PKA, it can lead to compensatory upregulation of PKAγ levels and activity.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Phosphodiesterase-4 inhibitor that prevents cAMP breakdown, endorsing the accumulation of cAMP within the cell and subsequent activation of PKAγ.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

Phosphodiesterase-3 inhibitor, leading to increased cAMP levels and thereby indirectly supporting the enhancement of PKAγ activity.

Glucagon trifluoroacetic acid salt

9007-92-5 (free base)sc-495801
1 mg
$480.00
(0)

Activates adenylate cyclase in hepatocytes which elevates cAMP and activates PKAγ, influencing glucose metabolism.

PGE1 (Prostaglandin E1)

745-65-3sc-201223
sc-201223A
1 mg
10 mg
$31.00
$145.00
16
(4)

Binds to its receptor and activates adenylate cyclase, increasing cAMP production and activating PKAγ.

Anagrelide

68475-42-3sc-491875
25 mg
$150.00
(0)

Originally developed as a phosphodiesterase 3 inhibitor, it increases cAMP levels and activates PKAγ, studied in the research of thrombocythemia.

NKH 477

138605-00-2sc-204130
sc-204130A
5 mg
50 mg
$223.00
$922.00
1
(0)

Water-soluble forskolin derivative that directly activates adenylate cyclase, thus increasing cAMP and activating PKAγ.